NeuroBo Pharmaceuticals, Inc. Gains 40.78%

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) rocketted at $3.97, a gain of 40.8%. On Mon, Jul 19, 2021, NRBO:NASDAQ touched a New 2-Week Intraday Low of $2.7. The stock appeared on our News Catalysts scanner on Mon, Jul 12, 2021 at 09:21 AM in the 'INVESTOR UPDATE' category. From Tue, Jul 06, 2021, the stock recorded 44.44% Up Days and 30.00% Green Days

The stock spiked on Mon, Jun 14, 2021 at $6.57 with a volume of 7M+, and its share price has been moving sideways in recent weeks.

About NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ)

NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.